Alaunos Therapeutics TCRT Insider Ownership

NASDAQ TCRT
$3.20 +0.23 (+7.74%)
As of: Oct 21, 2026 · 2:39 PM EDT

Insider Holdings by Owner

262.49K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
9.74%
▲+1.38% pp QoQ
Shares Held by Insiders
242.19K
filed for Sep 2026
▲+16.51% QoQ
Shares Outstanding
2.49Mn
2,486,140 shares
Direct Holdings
166.27K
Indirect: 75.92K
Net Shares Traded (QoQ)
+34.32K
net buying in Sep 2026
Insiders Holding Shares
9
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Over the trailing 12 months, TCRT insiders made no open-market trades in the stock.

Form 4 Holdings

Insiders Holding TCRT

Insiders 9
Shares held 262.49K
Of outstanding 10.56%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Robert W Postma Director 80,438 0 80,438 30.6% 08 Oct, 2026
2 Jaime Vieser Director 70,311 0 70,311 26.8% 08 Oct, 2026
3 Holger Weis Ceo 49,047 0 49,047 18.7% 06 Oct, 2026
4 Michael Allen Jerman Director 44,749 0 44,749 17.0% 08 Oct, 2026
5 Ferdinand Groenewald Vice President Of Finance 10,775 0 10,775 4.1% 20 Aug, 2025
6 Kevin S. Sr. Boyle Chief Executive Officer 5,322 0 5,322 2.0% 05 Sep, 2023
7 James Huang Director 1,256 0 1,256 0.5% 24 Jun, 2022
8 Mary Thistle Director 300 0 300 0.1% 24 Jun, 2022
9 Christopher Bowden Director 294 0 294 0.1% 24 Jun, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

592 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
06 Oct, 2026 Michael Allen Jerman Director Acquired A 20,990 $0.74 $15.62K 44,749 Direct
06 Oct, 2026 Jaime Vieser Director Acquired A 22,669 $0.74 $16.87K 70,311 Direct
06 Oct, 2026 Robert W Postma Director Acquired A 21,829 $0.74 $16.25K 80,438 Direct
06 Oct, 2026 Holger Weis Ceo Acquired A 23,564 $0.74 $17.54K 49,047 Direct
06 Aug, 2026 Holger Weis Ceo Acquired A 4,363 $2.01 $8.77K 25,483 Direct
23 Jul, 2026 Robert W Postma Director Acquired A 8,463 $1.92 $16.25K 58,609 Direct
23 Jul, 2026 Holger Weis Ceo Acquired A 4,568 $1.92 $8.77K 21,120 Direct
23 Jul, 2026 Michael Allen Jerman Director Acquired A 8,138 $1.92 $15.62K 23,759 Direct
23 Jul, 2026 Jaime Vieser Director Acquired A 8,789 $1.92 $16.87K 47,642 Direct
30 Jun, 2026 Holger Weis Chief Executive Officer Acquired A 3,880 $2.26 $8.77K 16,552 Direct
12 Jun, 2026 Holger Weis Chief Executive Officer Acquired A 7,761 $2.26 $17.54K 12,672 Direct
22 May, 2026 Holger Weis Chief Executive Officer Acquired A 3,700 $2.37 $8.77K 4,911 Direct
29 Apr, 2026 Michael Allen Jerman Director Acquired A 6,032 $2.59 $15.62K 15,621 Direct
29 Apr, 2026 Jaime Vieser Director Acquired A 6,515 $2.59 $16.87K 38,853 Direct
29 Apr, 2026 Robert W Postma Director Acquired A 6,274 $2.59 $16.25K 50,146 Direct
12 Jan, 2026 Robert W Postma Director Acquired A 5,622 $2.89 $16.25K 43,872 Direct
12 Jan, 2026 Jaime Vieser Director Acquired A 5,839 $2.89 $16.87K 32,338 Direct
21 Nov, 2025 Robert W Postma Director Acquired A 5,142 $3.16 $16.25K 38,250 Direct
21 Nov, 2025 Jaime Vieser Director Acquired A 5,340 $3.16 $16.87K 26,499 Direct
21 Nov, 2025 Michael Allen Jerman Director Acquired A 4,183 $3.16 $13.22K 4,183 Direct